Taiho Pharmaceutical Invests in New Venture Capital Fund
TOKYO, Aug. 29, 2019 /Kyodo JBN- AsiaNet/ -- Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President and Representative Director: Masayuki Kobayashi) announced on August 29 that the company has entered into an agreement to invest up to US$30 million in Remiges BioPharma Fund II, LP a biopharma ...
Authors: LATEST ASIANET NEWS RELEASES